Back to Journals » Journal of Experimental Pharmacology » Volume 3
Effects of single-dose morning and evening administration of pravastatin on antioxidant markers in cholesterol-fed rabbits
Authors Shams S
Published 13 May 2011 Volume 2011:3 Pages 51—58
DOI https://doi.org/10.2147/JEP.S19449
Review by Single anonymous peer review
Peer reviewer comments 4
Sahar Mohamed Kamal
Department of Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Background: Accurate timing of statin administration is considered important to obtain the best hypolipidemic effect. Pravastatin is one of the currently prescribed hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, and was chosen in this study to evaluate its antioxidant effect when administered as a single daily dose in the morning versus evening in cholesterol-fed rabbits.
Methods: This 12-week study was performed in New Zealand rabbits, divided into four groups (n = 6 each), ie, normocholesterolemic controls; cholesterol 1% diet, nontreated ; cholesterol 1% diet treated with pravastatin in the morning; and cholesterol 1% diet treated with pravastatin in the evening. Plasma total cholesterol levels, superoxide dismutase enzyme levels in erythrocyte lysates, thiobarbituric acid-reactive substance content, catalase, and glutathione enzyme activity in liver homogenates from the tested rabbits were measured.
Results: Both morning and evening treatment with pravastatin significantly improved all the measured antioxidant markers in comparison with nontreated cholesterol-fed rabbits. However, results obtained with evening dosing were better than with morning dosing.
Conclusion: The antioxidant profile of pravastatin is better when the drug is administered in the evening rather than in the morning.
Keywords: pravastatin, chronotherapy, antioxidant markers, cholesterol-fed rabbits
© 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.